PTEN and prostate cancer: It is well-established that PTEN loss, inactivation, or attenuation is a common genetic feature in multiple cancers, with PTEN loss of heterozygosity (LoH) found in more than a quarter of glioblastomas, prostate cancers, breast cancers, and melanomas [66].